Company: CMND
Filing Date: 2025-01-22
Form Type: POS AM
Source: 0001213900-25-005519
Chunk: 25

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: POS AM
Chunk 25
---
 even though an action,
if successful, might benefit us and our shareholders. A shareholder’s investment may be harmed to the extent we pay the costs of
settlement and damage awards against directors and officers pursuant to these indemnification provisions.

Insofar as indemnification for liabilities under
the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been
informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore
unenforceable. There is no pending litigation or proceeding naming any of our directors or officers as to which indemnification is being
sought, nor are we aware of any pending or threatened litigation that may result in claims for indemnification by any director or officer.

Listing

Our Common Shares are listed on the Nasdaq Capital
Market under the symbol “CMND.”

Transfer Agent and Registrar

The transfer agent and registrar for our Common
Shares will be Computershare Limited.

<div align='center'>Comparison of Shareholder Rights</div>

We are a corporation
governed by the BCBCA. The following discussion summarizes material differences between the rights of holders of Common Shares and the
holders of the common stock of a typical corporation incorporated under the laws of the state of Delaware, which result from differences
in governing documents and the laws of British Columbia and Delaware. This summary is qualified in its entirety by reference to the Delaware
General Corporation Law, or the DGCL, the BCBCA, and our articles.

<div align='center'>14</div>

|                                                        |     | Delaware                                                                                                                               |     | British Columbia                                                                                                                        |
| Stockholder/Shareholder                                
 Approval of Business Combinations; Fundamental Changes |     | Under the DGCL, certain fundamental changes such as amendments                                                                         
 to the certificate of incorporation, a merger, consolidation, sale, lease, exchange or other disposition of all or substantially       
 all of the property of a corporation not in the usual and regular course of the corporation’s business, or a dissolution               
 of the corporation, are generally required to be approved by the holders of a majority of the outstanding stock entitled to vote       
 on the matter, unless the certificate of incorporation requires a higher percentage.                                                   
 However, under the DGCL, mergers in which less than 20% of a corporation’s                                                             
 stock outstanding immediately prior to the effective date of the merger is issued generally do not require stockholder approval.       
 In certain situations, the approval of a business combination